North Star Asset Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$405K Buy
4,669
+1,470
+46% +$141K 0.02% 263
2025
Q4
$307K Sell
3,199
-1,775
-36% -$172K 0.01% 280
2025
Q3
$474K Buy
4,974
+330
+7% +$30.3K 0.02% 236
2025
Q2
$405K Sell
4,644
-318
-6% -$27K 0.02% 248
2025
Q1
$446K Sell
4,962
-121
-2% -$10.8K 0.02% 226
2024
Q4
$406K Buy
5,083
+578
+13% +$50K 0.02% 232
2024
Q3
$406K Buy
4,505
+84
+2% +$7.07K 0.02% 233
2024
Q2
$348K Buy
4,421
+229
+5% +$18.8K 0.02% 241
2024
Q1
$365K Buy
4,192
+177
+4% +$15.1K 0.02% 241
2023
Q4
$331K Sell
4,015
-404
-9% -$30.8K 0.02% 245
2023
Q3
$346K Sell
4,419
-1,499
-25% -$125K 0.02% 238
2023
Q2
$521K Sell
5,918
-115
-2% -$9.9K 0.03% 204
2023
Q1
$486K Buy
6,033
+1,149
+24% +$93.6K 0.03% 206
2022
Q4
$380K Sell
4,884
-125
-2% -$10.1K 0.02% 229
2022
Q3
$404K Sell
5,009
-202
-4% -$18.2K 0.03% 211
2022
Q2
$468K Sell
5,211
-225
-4% -$22.8K 0.03% 198
2022
Q1
$603K Buy
5,436
+53
+1% +$5.6K 0.03% 191
2021
Q4
$557K Sell
5,383
-250
-4% -$28.9K 0.03% 206
2021
Q3
$706K Buy
5,633
+775
+16% +$100K 0.04% 188
2021
Q2
$603K Sell
4,858
-300
-6% -$37.7K 0.03% 196
2021
Q1
$609K Sell
5,158
-134
-3% -$15.7K 0.04% 187
2020
Q4
$620K Buy
5,292
+813
+18% +$89.5K 0.04% 183
2020
Q3
$465K Hold
4,479
0.03% 186
2020
Q2
$411K Buy
4,479
+50
+1% +$4.79K 0.03% 194
2020
Q1
$399K Sell
4,429
-242
-5% -$25.7K 0.04% 191
2019
Q4
$530K Buy
4,671
+80
+2% +$8.78K 0.04% 198
2019
Q3
$499K Sell
4,591
-49
-1% -$5.11K 0.04% 199
2019
Q2
$452K Sell
4,640
-165
-3% -$15.1K 0.04% 201
2019
Q1
$438K Hold
4,805
0.04% 205
2018
Q4
$437K Sell
4,805
-405
-8% -$37.8K 0.04% 200
2018
Q3
$513K Sell
5,210
-1,975
-27% -$183K 0.04% 205
2018
Q2
$615K Sell
7,185
-310
-4% -$25.9K 0.05% 190
2018
Q1
$601K Sell
7,495
-1,250
-14% -$103K 0.05% 187
2017
Q4
$706K Buy
8,745
+1,050
+14% +$84.1K 0.06% 168
2017
Q3
$598K Sell
7,695
-200
-3% -$16.6K 0.06% 171
2017
Q2
$701K Sell
7,895
-550
-7% -$46.4K 0.07% 162
2017
Q1
$680K Sell
8,445
-150
-2% -$11.7K 0.07% 159
2016
Q4
$612K Sell
8,595
-3,155
-27% -$248K 0.07% 161
2016
Q3
$1.01M Sell
11,750
-5,680
-33% -$495K 0.11% 140
2016
Q2
$1.51M Sell
17,430
-7,987
-31% -$646K 0.18% 116
2016
Q1
$1.91M Sell
25,417
-1,815
-7% -$137K 0.22% 110
2015
Q4
$2.1M Sell
27,232
-4,368
-14% -$329K 0.25% 107
2015
Q3
$2.12M Sell
31,600
-11,900
-27% -$876K 0.26% 106
2015
Q2
$3.22M Sell
43,500
-16,585
-28% -$1.27M 0.37% 98
2015
Q1
$4.69M Sell
60,085
-23,095
-28% -$1.75M 0.53% 72
2014
Q4
$6.01M Sell
83,180
-19,430
-19% -$1.35M 0.69% 58
2014
Q3
$6.36M Sell
102,610
-7,159
-7% -$455K 0.76% 53
2014
Q2
$7M Sell
109,769
-1,580
-1% -$96K 0.82% 47
2014
Q1
$6.85M Sell
111,349
-3,035
-3% -$177K 0.82% 48
2013
Q4
$6.56M Sell
114,384
-4,339
-4% -$246K 0.8% 47
2013
Q3
$6.32M Sell
118,723
-4,450
-4% -$239K 0.83% 46
2013
Q2
$6.34M Buy
+123,173
New +$6.09M 0.89% 37

Other funds holding MDT

North Star Asset Management's MDT Position: Q1 2026 in Review

North Star Asset Management increased its Medtronic (MDT) stake by 46% in Q1 2026, buying an estimated $141K and bringing the position to 4,669 shares worth $405K. The position accounts for 0.02% of the portfolio, ranked #263.

North Star Asset Management first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $7M in Q2 2014. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • North Star Asset Management held 4,669 shares of Medtronic worth $405K as of Q1 2026.
  • North Star Asset Management bought 1,470 Medtronic shares in Q1 2026, an estimated $141K.
  • Medtronic made up 0.02% of North Star Asset Management's portfolio in Q1 2026, its #263 holding.
  • North Star Asset Management first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • North Star Asset Management's Medtronic position peaked at $7M in Q2 2014.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on North Star Asset Management's 13F filing for Q1 2026, filed 6 May 2026.